4:04pm ET
Investing
Orexigen, Advaxis Tumble into Tuesday’s 52-Week Low Club
Orexigen, Advaxis, Globalstar, and Piedmont Office Realty Trust all posted new 52-week lows Tuesday.
Paul Ausick
Companies
Orexigen Therapeutics, Inc.
$0.22
▼ $0.12 (−34.42%) today
Markets closed · 9:06pm ET
Today · % change
OREX Coverage
Paul Ausick 4:04pm ET
Investing
Anthera, Orexigen Submerge in Monday’s 52-Week Low Club
Anthera Pharmaceuticals, Orexigen Therapuetics, VEON, and New Gold all posted new 52-week lows Monday.
Paul Ausick 12:15pm ET
Health and Healthcare
Wednesday’s Top 5 Biopharma Movers
A few biotech and pharma companies were on the move Wednesday, some making absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health…
Chris Lange 9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Chipotle, Oracle, Orexigen, PulteGroup, Reynolds American, Valeant and More
The top analyst upgrades, downgrades and initiations seen on Wednesday, March 16, include Chipotle Mexican Grill, Oracle, Orexigen Therapeutics, PulteGroup, Reynolds American and Valeant Pharmaceuticals.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Huntington Bancshares, Nucor, Orexigen, SanDisk, Square, VIVUS and Many More
The top analyst upgrades, downgrades and initiations seen on Monday, February 29, include Huntington Bancshares, Nucor, Orexigen Therapeutics, SanDisk, Square and VIVUS.
9:50am ET
Health and Healthcare
Orexigen Therapeutics Receives $15 Million Milestone Payment
Orexigen Therapeutics has announced receipt of the first of three potential $15 million anniversary milestone payments from Takeda Pharmaceuticals.
Chris Lange 2:15pm ET
Health and Healthcare
Are Problems at Orexigen Still Just Getting Started?
Orexigen Therapeutics shares plunge after termination of cardiovascular outcomes study of the obesity drug Contrave.
Chris Lange 11:00am ET
Investing
8 Analyst Stocks Under $10 With Huge Upside Targets
The last full week of March was choppy and took away most of the 2015 gains for the Dow and the S&P. Still, investors keep looking for value.
2:51pm ET
Health and Healthcare
Wells Fargo’s Top Biotech Stocks for 2015
ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo expects that…
1:50pm ET
Health and Healthcare
Is Orexigen Really Worth Over 50% More?
Merrill Lynch released an analyst report for Orexigen Therapeutics that sees more than 50% upside for the company.
Chris Lange 8:35am ET
Health and Healthcare
Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential
A new report from Merrill Lynch highlights five biotechs that have been absolutely crushed but have outstanding potential and catalysts that can drive them much higher.
Lee Jackson 9:10am ET
Investing
9 Analyst Stocks to Buy Under $10 With Massive Upside Potential
Many investors believe stocks priced under $10 have much more upside than traditional Dow and S&P 500 stocks.
11:50am ET
Health and Healthcare
Credit Suisse Positive on Some Biotechs, Very Cautious on Others
Credit Suisse has launched new biotech coverage on Wednesday with two analysts at the firm.
11:10am ET
Investing
Twelve Analyst Stocks Trading Under $10 With Huge Implied Upside
ThinkstockStocks have pulled back from their all-time highs after escalation of civil war in Iraq, but Friday managed to close higher. Investors remain bullish, and they keep hearing that the bull market…
9:10am ET
Investing
Three Analyst Stocks Projected to Double, or More
These are the three analysts stock picks from Wall Street in recent days that were projected to have implied upside of 100% or more.